4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid has been researched along with sr 11217 in 2 studies
| Studies (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Trials (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Recent Studies (post-2010) (4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid) | Studies (sr 11217) | Trials (sr 11217) | Recent Studies (post-2010) (sr 11217) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 9 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DL; Dawson, MI; Elstner, E; Kerner, B; Kizaki, M; Koeffler, HP; Pakkala, S | 1 |
| Blomhoff, HK; Blomhoff, R; Dawson, MI; Gandhi, U; Lømo, J; Natarajan, V; Smeland, EB; Ulven, S | 1 |
2 other study(ies) available for 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid and sr 11217
| Article | Year |
|---|---|
Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
Topics: Animals; Cell Differentiation; Cell Division; Humans; Leukemia, Promyelocytic, Acute; Mice; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors; Tumor Cells, Cultured | 1994 |
RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Topics: Alitretinoin; Apoptosis; B-Lymphocytes; CD40 Antigens; CD40 Ligand; DNA; DNA-Binding Proteins; Gene Expression; Humans; Immunoglobulin M; Interleukin-4; Ligands; Lymphocyte Activation; Membrane Glycoproteins; Receptors, Retinoic Acid; Retinoid X Receptors; Retinoids; Transcription Factors; Transcription, Genetic; Transfection; Tretinoin | 1998 |